Inhibitory effect of erythromycin on interleukin 8 production by 1α,25-dihydroxyvitamin D3-stimulated THP-1 cells

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 6, 1996, Pages 1548-1551

  Fujii, Takeshi ^a   Kadota, Jun Ichi ^a   Morikawa, Toru ^a   Matsubara, Yuichi ^a   Kawakami, Kaoru ^a   Iida, Keiko ^a   Shirai, Ryo ^a   Taniguchi, Haruko ^a   Kaseda, Makoto ^a   Kawamoto, Sadahiro ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CALCITRIOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; INTERLEUKIN 8; JOSAMYCIN; MIOKAMYCIN; PIPERACILLIN; ROXITHROMYCIN;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; LEUKOCYTE CULTURE; LUNG ALVEOLUS MACROPHAGE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN SECRETION;

ANTI-BACTERIAL AGENTS; CALCITRIOL; CELL LINE; ERYTHROMYCIN; HUMANS; INTERLEUKIN-8; MONOCYTES;

EID: 0029888562     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.6.1548     Document Type: Article

References (26)

1. Anderson, R., C. E. J. Van Rensburg, G. Jooné, and P. T. Lukey. 1987. An in-vitro comparison of the intraphagocytic bioactivity of erythromycin and roxithromycin J Antimicrob. Chemother. 20(Suppl. B):57-68.
2. Aoshiba, K., A. Nagai, and K. Konno. 1995. Erythromycin shortens neutrophil survival by accelerating apoptosis. Antimicrob. Agents Chemother. 39: 872-877.
3. Baggiolini, M., A. Walt, and S. L. Kunkel. 1989. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J. Clin. Invest 84:1045-1049
4. Fujii, T., J. Kadota, K. Kawakami, K. Iida, R. Shirai, M. Kaseda, S. Kawamoto, and S. Kohno. 1995. Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. Thorax 50:1246-1252
5. Gallay, P., C. Barras, P. S. Tobias, T. Calandra, M. P. Glauser, and D. Heumann. 1994 Lipopolysaccharide (LPS)-binding protein in human serum determines the tumor necrosis factor response of monocytes to LPS. J. Infect. Dis. 170:1319-1322
6. Homma, H., A. Yamanaka, S. Tanimoto, M. Tamura, Y. Chijimatsu, S. Kira, and T. Izumi. 1983. Diffuse panbronchiolitis. Chest 83:63-69
7. Ichikawa, Y., H. Ninomiya, H. Koga, M. Tanaka, M. Kinoshita, N. Tokunaga, T. Yano, and K. Oizumi. 1992. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am. Rev. Respir. Dis 146:196-203
8. Iwata, M., T. V. Colby, and M. Kitaichi. 1994. Diffuse panbronchiolitis: diagnosis and distinction from various pulmonary diseases with centrilobular interstitial foam cell accumulations Hum Pathol. 25:357-363.
9. Kadota, J., O. Sakito, S. Shigeru, H. Sawa, H. Mukae, H. Oda, K. Kawakami, K. Fukushima, K. Hiratani, and K. Hara. 1993. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am. Rev. Respir. Dis. 147:153-159.
10. Khair, O. A., J. L. Devalia, M. M. Abdelaziz, R. J. Sapsford, and R. J. Davies. 1995. Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells Eur. Respir J 8:1451-1457.
11. Kudoh, S., T. Uetake, K. Hagiwara, M. Hirayama, L. Hus, H. Kimura, and Y. Sugiyama. 1987. Clinical effect of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. Jpn. J. Thorac. Dis. 25:632-642.
12. Lee, C. T., A. M. Fein, M. Lippmann, H. Holtzman, P. Kimbel, and G. Weinbaum. 1981. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N. Engl J Med 304:192-196.
13. Martin, T. R., G. Rubenfeld, K. P. Steinberg, L. D. Hudson, G. Raghu, A. M. Moriatry, D. J. Leturcq, P. S. Tobias, and R. J. Ulevitch. 1994 Endotoxin, endotoxin-binding protein, and soluble CD14 are present in bronchoalvcolar lavage fluid of patients with adult respiratory distress syndrome Chest 105(Suppl.):55S-56S
14. McCord, J. M., and I. Fridovich. 1978. The biology and pathology of oxygen radicals Ann. Intern. Med. 89:122-127.
15. McElvaney, N. G., H. Nakamura, P. Birrer, C. A. Hebert, W. L. Wong, M. Alphonso, J. B. Baker, M. A. Catalano, and R. G. Crystal. 1992. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J. Clin. Invest 90:1296-1301.
16. Mitsuyama, T., T. Tanaka, K. Hidaka, M. Abe, and N. Hara. 1995. Inhibition by erythromycin of superoxide anion production by human polymorphonuclear leukocytes through the action of cyclic AMP-dependent protein kinase. Respiration 62:269-273.
17. Mukae, H., M. Hirota, S. Kohno, K. Komori, K. Fukushima, K. Hiratani, J. Kadota, and K. Hara. 1993 Elevation of tumor-associated carbohydrate antigens in patients with diffuse panbronchiolitis. Am Rev Respir. Dis 148:744-751.
18. Nagai, H., H. Shishido, R. Yoneda, E. Yamaguchi, A. Tamura, and A. Kurashima. 1991. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis Respiration 58:145-149.
19. Oda, H., J. Kadota, S. Kohno, and K. Hara. 1995. Leukotriene B4 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis. Chest 108:116-122.
20. Oishi, K., F. Sonoda, S. Kobayashi, A. Iwagaki, T. Nagatake, K. Matsushima, and K. Matsumoto. 1994. Role of interleukin-8 and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Infect. Immun. 62:4145-4152.
21. Prokesch, R. C., and W. L. Hand. 1982 Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 21:373-380.
22. Richman-Eisenstat, J. B. Y., P. G. Jorens, C. A. Hebert, I. Ueki, and J. A. Nadel. 1993. Interleukin-8: an important in sputum of patients with chronic inflammatory airway disease. Am. J Physiol. 264:L413-L418.
23. Sakito, O., J. Kadota, S. Kohno, K. Abe, R. Shirai, and K. Hara. 1996. Interleukin-1b, tumor necrosis factor a and interleukin-8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis a potential mechanism of macrolide therapy. Respiration 63:42-48.
24. Schumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science 249:1429-1431.
25. Tobias, P. S., K. Soldau, L. Kline, J.-D. Lee, K. Kato, T. P. Martin, and R. J. Ulevitch. 1993. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein. J. Immunol. 150:3011-3021
26. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.